Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. FDA Long-Term Globalization Strategy Under Development

This article was originally published in PharmAsia News

Executive Summary

Coping with an increasingly global device and drug industry will require a paradigm shift that relies less on U.S. FDA's own staff and more on data and resource sharing with other countries, the agency says

You may also be interested in...



U.S. FDA Warning Letters To Foreign Manufacturing Facilities Rise Dramatically

U.S. FDA's device center is sending a record number of warning letters to foreign facilities as the agency continues its efforts to more effectively oversee product manufacturing located outside the U.S

U.S. FDA Warning Letters To Foreign Manufacturing Facilities Rise Dramatically

U.S. FDA's device center is sending a record number of warning letters to foreign facilities as the agency continues its efforts to more effectively oversee product manufacturing located outside the U.S

U.S. FDA Assessing Capability To Amplify Surveillance Of Indian, Chinese OTC Manufacturers - PharmAsia Summit

SAN FRANCISCO - U.S. FDA is gathering information that will likely help the agency intensify its gaze on Indian and Chinese OTC, nutraceutical and traditional medicine manufacturers that use a registration loophole to export products to the U.S. under less stringent oversight

Related Content

UsernamePublicRestriction

Register

SC077138

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel